A new wind is blowing through the world of psychedelics. What for decades was seen as dangerous, forbidden and taboo is increasingly proving to be a source of insight, healing and scientific curiosity.
Psychedelics - substances like LSD, magic mushrooms, truffles and MDMA - are about to regain their place in medicine. And yet: in criminal law, they are still treated as a crime, as if they threaten society.
The history of psychedelics
The use of psychedelics is as old as humanity itself. In virtually every culture on earth, there are rituals in which plants or fungi are used to expand consciousness, heal the soul or make contact with the divine.
In the Amazon, ayahuasca has been drunk for thousands of years, in Mexico, psilocybin-containing mushrooms were revered by the Mazatec shamans, and in North America, indigenous peoples used the peyote cactus as a sacred sacrament.
According to the Stoned Ape Theory by noted "psychedelics advocate" Terence McKenna, our distant ancestors are thought to have eaten magic mushrooms growing wild. The idea: these early encounters with psychedelics may have played a role in the accelerated development of language, creativity and consciousness - and thus in the evolution of modern humans.
In the 1940s and 1950s, interest in psychedelics revived. When Swiss chemist Albert Hofmann accidentally discovered the psychoactive effects of LSD in 1943, it was the beginning of a completely new chapter in Western psychiatry.
Psychologists and psychiatrists at the time used LSD as an aid in psychotherapy, trauma and addiction treatment, and artists and intellectuals also experimented with it to deepen insight and creativity.
In the 1960s, use blew over to the general public. LSD became the symbol of counterculture: the hippie movement, flower power, and artists such as The Beatles, Jefferson Airplane and Pink Floyd sang openly about their experiences with mind-altering drugs.
Psychedelics then stood not only for mind expansion, but also for social change - for freedom, peace and a different way of thinking. That cultural explosion brought fear to governments, who feared that psychedelics would undermine authority and order. And so began the long period of repression that virtually shut down scientific research.
Half a century later, we see the consequences: millions of people struggling with depression or addiction, while potentially effective therapies, (self)medication and research with psychedelics are banned.
The 'Stoned Ape' theory
How psychedelics were banned
Psychedelics were banned by the (U.S.) government in the 1960s. President Richard Nixon even called LSD a danger to the state. When activists in the Netherlands ("Provo's") in 1966 threatened to disrupt the royal wedding between Princess Beatrix and Claus von Amsberg by feeding sugar cubes containing LSD to police horses, the government panicked and it was quickly put on the Opium list in our country as well.
Along with this ban, all promising research into the possibilities of psychedelic therapy was also stopped. Media campaigns were launched to scare the people about the risks of psychedelics (see, for example, this video and this video).
And so countless fables and misconceptions have arisen about perhaps one of Mother Nature's greatest miracles: psychedelics.
Still, the prohibition of psychedelics has not prevented these healing substances from regaining plenty of interest. In more and more countries, the use of psychedelics is now allowed again (albeit sparsely or only in therapeutic settings), or there are plans to legalize them. Fortunately, there is also plenty of research being done on psychedelics and their possible medical and therapeutic applications.
The benefits of psychedelics and the call for legalization are so great that it will become increasingly difficult for the government to maintain legal prohibition. And, almost every study shows what experienced users have long known, namely that psychedelics do not belong in the criminal law, but in the doctor's medicine cabinet, on the therapist's desk and in the smartshop's showcase.
A means, not a crime
The wry thing is that many of the dangers surrounding psychedelics stem precisely from prohibition itself.
Because use has been pushed to the margins, quality control, guidance and education are lacking. Anyone struggling with trauma or depression today may take a cocktail of antidepressants, sleep aids and tranquilizer pills without a problem - but risks prosecution if they choose a natural molecule that has been found in mushrooms for millions of years.
The idea that psychedelics would be a crime doesn't hold up once you look at the facts.
There is no scientific evidence that controlled use of substances such as LSD or psilocybin cause structural damage or are addictive. On the contrary, they have low/no toxicity, no physical addiction potential and can even lead to lasting behavioral improvements, if applied properly.
They are tools that, in the right context, enhance self-reflection, empathy and connection - traits that could heal rather than harm society.
The real problem lies not in the substance itself, but in the way policy looks at it. By criminalizing psychedelics, we criminalize curiosity, healing and self-exploration. We are putting people who seek help in the corner of "criminals," when in fact they are often seeking meaning, recovery or relief from mental suffering.
This is not only counterproductive, but ethically untenable at a time when science shows time and again that these substances, under supervision, actually lead to less suffering.
So the question is no longer whether psychedelics have therapeutic potential.
The question is: How many more people do we have to let suffer before policy catches up with science - and humanity?
The future of psychedelics
What we see in recent years (since about 2010) is not a return to old rituals, but a new phase of scientific and social acceptance.
Governments and research institutes are again investing (little by little) in understanding the therapeutic value of psychedelics. Within the European Union, grants are being provided for clinical research on psilocybin and other mind-altering substances, and interest is also growing within academia in the Netherlands.
At institutions such as the University Medical Center Utrecht, Radboud University Nijmegen and Maastricht University, studies are underway on the use of psilocybin in depression, anxiety disorders and addiction. The tone of public debate is visibly changing: psychedelics are increasingly discussed in medical conferences, policy papers and media - not as a drug problem, but as a potential drug.
It is expected that within the next decade, psychedelics will become part of mainstream therapeutic and psychiatric treatments - not as a panacea, but as a catalyst for insight, behavioral change and recovery.
And perhaps then we will look back on this time and wonder: how could we ever have thought that criminal justice knew better about healing than science?
Recent studies
Dozens of peer-reviewed studies have appeared in recent years, opening the door to a new therapeutic era. Below is a selection of the most influential studies:
Psilocybin in major depression (JAMA Psychiatry, 2021) - Clinical trials in adults with MDD showed rapid and sustained improvement in depressive symptoms after psilocybin-assisted therapy.
Psilocybin vs. escitalopram (NEJM, 2021) - A double-blind study compared psilocybin with a widely used antidepressant. The results: similar effectiveness, but psilocybin showed stronger improvements on secondary measures such as well-being and quality of life.
Single-dose psilocybin in depression (JAMA, 2023) - One guided dose led to rapid symptom reduction with a favorable safety profile; follow-up study on durability ongoing.
Psilocybin in alcohol dependence (JAMA Psychiatry, 2022) - In a randomized trial of 93 participants, patients who received psilocybin drank significantly less heavily than the placebo group.
MDMA-assisted therapy in PTSD (Nature Medicine, 2021 & 2023) - Phase 3 studies show MDMA combined with psychotherapy greatly reduced PTSD symptoms and was generally well tolerated.
Psilocybin and smoking cessation (Johns Hopkins, 2014-2021) - Pilot study and follow-up showed unusually high abstinence rates in smokers receiving psilocybin supported therapy.
LSD in existential anxiety and cluster headaches (Switzerland, 2014-2024) - Studies indicate marked reductions in anxiety and headache frequency with low and medium doses of LSD, with a favorable safety profile.
Australia & Canada as pioneers (2023-2025) - Reclassification and special consent programs allow physicians to prescribe or supervise psychedelic therapy, providing practical clinical data outside the laboratory.
How strong is the research?
💪 Strong: MDMA in PTSD, psilocybin in depression
Multiple Phase 3 studies show that MDMA-assisted therapy significantly reduces PTSD - even in patients who were therapy-resistant for years. Similarly, psilocybin showed rapid and sustained improvement in major depression in controlled studies. Both treatments have now received breakthrough therapy status.
🌱 Promising: Psilocybin in addiction and anxiety disorders, LSD in existential anxiety and cluster headaches
Research suggests that psychedelics may have broader applications. Psilocybin reduced alcohol and nicotine addiction, LSD-assisted therapy showed improved anxiety and pain scores in terminally ill patients, and there is evidence of relief in migraine and cluster headaches.
🔬 Early stage: Microdosing, neurodegenerative disorders, cognitive performance
Microdosing with LSD or psilocybin shows interesting patterns in mood and focus. In addition, experimental research on neuroplasticity and inflammation inhibition in the brain is ongoing, with potential applications in Alzheimer's and Parkinson's disease - a fascinating but fledgling field of research.
From prohibition to connection
The discussion about psychedelics is bigger than just drug policy.
It is about our view of mental health, of freedom, and of the role of consciousness in our lives.
Psychedelics do not belong in the prison of fear, but in the toolbox of understanding.
If we have learned anything from the past few decades, it is this:
where fear closed the door, knowledge opens it again.
💭 "What was once forbidden out of fear can now be healed through insight."
- Microvibes
